MRI scan study to improve prostate detection
Part of Cancer, Kidney & urinary clinical trials.
This trial studies special MRI images to learn how well they can find prostate cancer before treatment. It may help doctors choose better next steps during biopsy or during active surveillance.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 and can give informed consent
- You have never been diagnosed with prostate cancer and are scheduled for a prostate biopsy
- OR you have prostate cancer and are on active surveillance, and you are scheduled for a biopsy
- Your PSA results (blood test) are being used to decide on biopsy, including cases with a prior negative biopsy
- You can safely have an MRI (no devices or scan safety issues) and you can lie flat for over 1 hour
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new MRI platform to better identify prostate issues before a biopsy. It is for people with elevated PSA whose doctor is considering a biopsy.
This study tests if a special MRI measurement (ADC) can improve how well a standard MRI finds prostate cancer. If you have a suspicious MRI and are scheduled for a biopsy, this might help better understand your results.
This study tests whether new MRI imaging methods can better identify and grade prostate cancer in men with elevated PSA levels. You would get an MRI scan to help doctors see if cancer is present and how aggressive it might be.
This study checks whether a detailed MRI method can help find prostate cancer earlier in people considered high risk. You may be asked to get an MRI and help the team see if it works well as a screening test.
This study uses repeat MRI scans to monitor men with an intermediate suspicion of prostate cancer, aiming to reduce unnecessary biopsies while still catching significant cancers early.
This study tests whether special MRI “risk maps” can help doctors better identify suspicious areas in the prostate during diagnosis. If you’re having an MRI followed by an MRI-guided biopsy, this may help improve how the biopsy targets areas of concern.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.